MoonLake Immunotherapeutics - Ordinary Shares - Class A
XNAS: MLTX
38.70 1.10 (2.93%)
351.6K XNAS Volume
XNAS 08 May, 2025 3:04 PM (EDT)
Watchlist
Portfolio
Share
My Notes
Operating Revenue TTM
Net profit TTM
Negative Net profit TTM
Net Profit Margin TTM %
Operating Revenue growth TTM %
Net Profit TTM Growth %
Negative Net Profit TTM Growth %